BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37236371)

  • 1. Workflow for Management of Gonadal Neoplasm in 2 Patients with Differences of Sex Development Enrolled in an Experimental Gonadal Tissue Cryopreservation Protocol.
    Abdallah AS; Arva NC; Finlayson CA; Melin-Aldana H; Papadakis JL; Rowell EE; Weisman AG; Whitehead J; Yerkes EB; Yuodsnukis BT; Johnson EK; Laronda MM
    Urology; 2023 Aug; 178():125-132. PubMed ID: 37236371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States.
    Siebert AL; Gomez-Lobo V; Johnson EK; Nahata L; Orwig KE; Pyle LC; Witchel SF; Finlayson C; Laronda MM
    Front Endocrinol (Lausanne); 2022; 13():990359. PubMed ID: 36733807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal Tissue Cryopreservation for Children with Differences of Sex Development.
    Johnson EK; Finlayson C; Finney EL; Harris CJ; Tan SY; Laronda MM; Lockart BA; Chen D; Rowell EE; Cheng EY; Yerkes EB
    Horm Res Paediatr; 2019; 92(2):84-91. PubMed ID: 31509845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal tumors in a contemporary cohort of patients with differences in sex development undergoing surgery - A multi-site study from the Pediatric Urologic Oncology Working Group of the societies for pediatric urology.
    Peard LM; Morin J; Flores V; Graham K; Taylor AS; Pope JC; Halstead V; Cost NG; Roberts EM; Makari JH; Cranford W; Saltzman AF
    J Pediatr Urol; 2023 Aug; 19(4):399.e1-399.e8. PubMed ID: 37117082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing an Institutional Gonadal Tissue Cryopreservation Protocol for Patients with Differences of Sex Development.
    Harris CJ; Corkum KS; Finlayson C; Rowell EE; Laronda MM; Reimann MB; Yerkes EB; Cheng EY; Johnson EK
    J Urol; 2020 Nov; 204(5):1054-1061. PubMed ID: 32379566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis.
    Chaudhry S; Tadokoro-Cuccaro R; Hannema SE; Acerini CL; Hughes IA
    J Pediatr Urol; 2017 Oct; 13(5):498.e1-498.e6. PubMed ID: 28351649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
    Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
    Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis.
    Wünsch L; Holterhus PM; Wessel L; Hiort O
    BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic outcomes of pre-malignant and invasive germ cell tumors in patients with differences in sex development - A systematic review.
    Morin J; Peard L; Vanadurongvan T; Walker J; Dönmez Mİ; Saltzman AF
    J Pediatr Urol; 2020 Oct; 16(5):576-582. PubMed ID: 32564942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
    Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
    Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal Tissue Cryopreservation for a Girl With Partial Androgen Insensitivity Syndrome.
    Finney EL; Johnson EK; Chen D; Lockart BA; Yerkes EB; Rowell EE; Madonna MB; Cheng EY; Finlayson CA
    J Endocr Soc; 2019 May; 3(5):887-891. PubMed ID: 31008422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
    Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
    Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Undetectable anti-Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis.
    Hannema SE; Wolffenbuttel KP; van Bever Y; Brüggenwirth HT; van den Berg SAA; Hersmus R; Oosterhuis JW; Looijenga LHJ
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):58-63. PubMed ID: 36905105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Gonads in Adults with Androgen Insensitivity: An International Survey.
    Tack LJW; Maris E; Looijenga LHJ; Hannema SE; Audi L; Köhler B; Holterhus PM; Riedl S; Wisniewski A; Flück CE; Davies JH; T'Sjoen G; Lucas-Herald AK; Evliyaoglu O; Krone N; Iotova V; Marginean O; Balsamo A; Verkauskas G; Weintrob N; Ellaithi M; Nordenström A; Verrijn Stuart A; Kluivers KB; Wolffenbuttel KP; Ahmed SF; Cools M
    Horm Res Paediatr; 2018; 90(4):236-246. PubMed ID: 30336477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
    Pyle LC; Nathanson KL
    Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development.
    Abacı A; Çatlı G; Berberoğlu M
    J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1019-27. PubMed ID: 25879315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
    Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
    Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal pelvic ultrasound or MRI does not rule out neoplasm in patients with gonadal dysgenesis and Y chromosome material.
    Ebert KM; Hewitt GD; Indyk JA; McCracken KA; Nahata L; Jayanthi VR
    J Pediatr Urol; 2018 Apr; 14(2):154.e1-154.e6. PubMed ID: 29317190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathologic features on gonadal changes of sexual developmental disorders in children].
    Yi P; Niu HL; Gao Q; Wang FH; Jia W; Chen ZR; Xia JQ; Li LP; Cao Y; Zeng RX
    Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):531-535. PubMed ID: 29996319
    [No Abstract]   [Full Text] [Related]  

  • 20. Turner Syndrome with Y Chromosome: Spontaneous Thelarche, Menarche, and Risk of Malignancy.
    Dabrowski E; Johnson EK; Patel V; Hsu Y; Davis S; Goetsch AL; Habiby R; Brickman WJ; Finlayson C
    J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):10-14. PubMed ID: 31465855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.